ES
EssilorLuxottica Société anonyme
ESLOY · OTC
$80.51 -0.79% (-$0.64)
1M -7.16%
Market Cap 66.3B €
P/E Ratio 29.84x
Div. Yield 2.89%
ROE 5.69%
Bulios Fair Price
$69.03
14.3% downside
Current Price
$80.51
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ESLOY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
7/9Valuation
61 /100
Fair P/FCF 18.34x
P/S 2.42x
P/B 1.71x
Growth
34 /100
Stable Rev. growth 3.77%
FCF growth 4.05%
Book val. growth 1.25%
Profitability
70 /100
Strong Net margin 8.13%
Op. margin 11.80%
FCF margin 13.22%
Quality
26 /100
Poor ROE 5.69%
ROA 3.48%
Asset turnover 0.43x
Debt
72 /100
Low Current ratio 0.99x
Int. coverage 14.06x
Net debt/EBITDA 2.17x
Stability
97 /100
Stable Rev. volatility 0.58%
EPS volatility 6.12%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ESLOY
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Francesco Milleri
Employees
203,791
Headquarters
Paris
Upcoming events
17 FEB
Earnings
Upcoming earnings report